MYndspan offers clinical-grade brain scanning as a consumer service, enabling proactive monitoring of brain health. It is the first company to make magnetoencephalography (MEG) – a high-resolution functional neuroimaging technology – accessible outside of research hospitals, allowing users to regularly assess their brain’s functional “age” and health. MYndspan operates specialized brain health centers equipped with MEG scanners.

During a session, a user’s brain activity is recorded non-invasively by the MEG device, which measures the magnetic fields produced by neural electrical activity. Proprietary algorithms then analyze this data to compute metrics like functional brain age, network stability, and other biomarkers of brain health. The analysis can reveal subtle functional changes (e.g. slowed network communication or abnormal oscillatory patterns) that precede clinical symptoms of cognitive decline.

By comparing scans over time, MYndspan’s platform tracks changes year-over-year, much like an annual physical, but for the brain. MYndspan’s MEG-based assessments are aimed at adults interested in early detection of neurodegenerative conditions (like Alzheimer’s) or monitoring brain health after injuries. For example, a middle-aged client with a family history of dementia might get scanned yearly to catch early functional signs of impairment and take action if needed. Athletes or individuals with repeated concussions could use it to monitor recovery of brain function. All scans are reviewed by experts, and personalized recommendations (lifestyle changes, follow-up medical consults, etc.) are provided. By democratizing access to advanced neuroimaging, MYndspan is shifting brain health from reactive to preventive, letting people extend the healthy lifespan of their minds.